Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer

NCT02448420 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Palbociclib
DRUG: Trastuzumab
DRUG: Endocrine therapy
DRUG: Chemotherapy
DRUG: Antibody-Drug Conjugates

Sponsor

SOLTI Breast Cancer Research Group